William Wilson Troutman serves as Executive at Eton Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, William Wilson Troutman has executed 2 insider transactions totaling $52.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 20, 2021 involved purchasing 5,000 shares valued at $22.1K.
William Wilson Troutman currently holds 23,027 shares of Eton Pharmaceuticals, Inc. (ETON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Wilson Troutman has been a net buyer of ETON stock. They have purchased $52.1K and sold $0 worth of shares.
William Wilson Troutman's most recent insider trade was on Aug 20, 2021, when they purchased 5,000 shares at $4.43 per share.
Get notified when new Form 4 filings are submitted
| $6.00 |
| Discretionary |